It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Metabolic clearance rate of insulin (MCRI) is thought to help maintain glucose homeostasis even in healthy subjects. However, the effect of a low carbohydrate/high fat (LCHF) diet on MCRI in healthy subject remains unclear. To investigate the effect of a 3-day eucaloric LCHF diet on MCRI in healthy subjects, we studied 42 healthy non-obese Japanese men. Each subject consumed a eucaloric LCHF diet for 3 days. Before and after the LCHF diet, intramyocellular lipid (IMCL) levels were measured using 1H-magnetic resonance spectroscopy, and glucose infusion rate (GIR) and MCRI were evaluated with a euglycemic hyperinsulinemic clamp. The LCHF diet increased MCRI by 10% and decreased steady state serum insulin (SSSI) and GIR during glucose clamp by 10% and 6%, respectively. To further investigate the role of MCRI, we divided subjects into high-responder (HR) and low-responder (LR) groups based on the median %change in MCRI. The LCHF diet increased IMCL and decreased SSSI during glucose clamp in the HR group, while those were not altered in the LR group. Our results suggested that a 3-day eucaloric LCHF diet increases MCRI in healthy non-obese Japanese men. This change seemed to be beneficial in terms of maintaining euglycemia during low carbohydrate availability.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Juntendo University Graduate School of Medicine, Department of Metabolism & Endocrinology, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
2 Juntendo University Graduate School of Medicine, Department of Metabolism & Endocrinology, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738); Juntendo University Graduate School of Medicine, Sportology Center, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
3 Juntendo University Graduate School of Medicine, Sportology Center, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
4 Juntendo University Graduate School of Medicine, Department of Metabolism & Endocrinology, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738); Juntendo University Graduate School of Medicine, Sportology Center, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738); Juntendo University Graduate School of Medicine, Center for Therapeutic Innovations in Diabetes, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738); Juntendo University Graduate School of Medicine, Center for Identification of Diabetic Therapeutic Targets, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)